Calcitonin (Miacalcin, Fortical)
Calcitonin is a naturally occurring hormone involved in calcium regulation and bone metabolism. Calcitonin can be injected or taken as a nasal spray. In women who are at least five years beyond
menopause, it slows bone loss and increases spinal
bone density. Women report that it also eases pain associated with bone fractures.
Raloxifene (Evista)
This drug is a selective estrogen receptor modulator (SERM) that has many estrogen-like properties. It is approved for
osteoporosis treatment and prevention, and can prevent bone loss at the spine, hip, and other areas of the body. Studies have shown that it can decrease the rate of vertebral fractures by 30 percent to 50 percent.
Estrogen Therapy (ET) or Hormone Therapy (HT)
These drugs, which have been used to treat the
symptoms of menopause, also are used to prevent bone loss. However, recent studies suggest that this might not be a good option for many women. The U.S. Food and Drug Administration (FDA) has made the following recommendations for taking ET and HT:
- Take the lowest possible doses of ET or HT for the shortest period of time to manage symptoms of menopause
- Talk with your doctor about using other osteoporosis medications instead.
Parathyroid Hormone or Teriparatide (Forteo)
Forteo is approved for osteoporosis treatment in postmenopausal women and for men who are at high risk for a fracture. It helps new bone to form and increases bone density. In postmenopausal women, it has been shown to reduce fractures in the spine, hip, foot, ribs, and wrist. In men, it can reduce fractures in the spine. It can be taken as a daily injection for up to 24 months.
Previous
Add this article to your Favorites
Email this article
Print